Nonsteroidal Anti-Inflammatory Drugs and the Heart

被引:90
作者
Patrono, Carlo [1 ]
Baigent, Colin [2 ,3 ]
机构
[1] Catholic Univ Sch Med, Dept Pharmacol, Rome, Italy
[2] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England
[3] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England
基金
英国医学研究理事会;
关键词
anti-inflammatory agents; non-steroidal; cyclooxygenase-2; inhibitors; heart failure; hypertension; myocardial infarction; stroke; LOW-DOSE ASPIRIN; PLATELET CYCLOOXYGENASE INHIBITION; INDIVIDUAL PARTICIPANT DATA; HEALTHY-SUBJECTS; RANDOMIZED-TRIALS; CLINICAL-PHARMACOLOGY; PROSTACYCLIN; NAPROXEN; COX-2; ATHEROTHROMBOSIS;
D O I
10.1161/CIRCULATIONAHA.113.004480
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:907 / 916
页数:10
相关论文
共 57 条
  • [21] Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man
    Hinz, Burkhard
    Cheremina, Olga
    Brune, Kay
    [J]. FASEB JOURNAL, 2008, 22 (02) : 383 - 390
  • [22] American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
    Hochberg, Marc C.
    Altman, Roy D.
    April, Karine Toupin
    Benkhalti, Maria
    Guyatt, Gordon
    McGowan, Jessie
    Towheed, Tanveer
    Welch, Vivian
    Wells, George
    Tugwell, Peter
    [J]. ARTHRITIS CARE & RESEARCH, 2012, 64 (04) : 465 - 474
  • [23] RECOVERY OF ENDOTHELIAL CELL PROSTACYCLIN PRODUCTION AFTER INHIBITION BY LOW-DOSES OF ASPIRIN
    JAFFE, EA
    WEKSLER, BB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1979, 63 (03) : 532 - 535
  • [24] Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
    Kearney, Patricia M.
    Baigent, Colin
    Godwin, Jon
    Halls, Heather
    Emberson, Jonathan R.
    Patrono, Carlo
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7553): : 1302 - 1305
  • [25] ARACHIDONATE METABOLISM IN VASCULAR DISORDERS
    MAJERUS, PW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (05) : 1521 - 1525
  • [26] Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
    McAdam, BF
    Catella-Lawson, F
    Mardini, IA
    Kapoor, S
    Lawson, JA
    FitzGerald, GA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) : 272 - 277
  • [27] Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries
    McGettigan, Patricia
    Henry, David
    [J]. PLOS MEDICINE, 2013, 10 (02)
  • [28] Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
    McGettigan, Patricia
    Henry, David
    [J]. PLOS MEDICINE, 2011, 8 (09)
  • [29] ARACHIDONIC-ACID METABOLITES AND THE INTERACTIONS BETWEEN PLATELETS AND BLOOD-VESSEL WALLS
    MONCADA, S
    VANE, JR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (20) : 1142 - 1147
  • [30] Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
    Murata, T
    Ushikubi, F
    Matsuoka, T
    Hirata, M
    Yamasaki, A
    Sugimoto, Y
    Ichikawa, A
    Aze, Y
    Tanaka, T
    Yoshida, N
    Ueno, A
    Ohishi, S
    Narumiya, S
    [J]. NATURE, 1997, 388 (6643) : 678 - 682